QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,086 signal articles · 526 in last 24h · 103,714 total before filter · latest 45m ago
526last 24h
2506last 7d
478● bullish (7d)
253● bearish (7d)
197publishers
AllMacro236Earnings1479M&A142Regulatory15Product5Analyst29
✕ clear all filtersticker: ^GSPCsentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Cathie Wood buys $2.1M of tumbling AI stock
TheStreet27d agobullish
Cathie Wood buys $2.1M of tumbling AI stock

Cathie Wood, head of Ark Investment Management, is known for buying her favorite tech stocks during market pullbacks. That's exactly what she just did, adding shares of an AI stock after a sharp selloff. In 2025, the flagship Ark Innovation ETF gained 35.49%, far outpacing the S&P 500’s ...

Beat the S&P 500 — here’s the strategy investors are switching to
TheStreet27d agobullish
Beat the S&P 500 — here’s the strategy investors are switching to

Transcript: Caroline Woods:Inflation expectations are creeping higher again and investors are wondering whether traditional income strategies are enough anymore. How does that change the income playbook? Matt Kaufman is global head of ETFs at Calamos Investments and joins us now. Matt, so good to ...

4 Brilliant Vanguard ETFs to Buy in July
24/7 Wall St.28d agobullish
4 Brilliant Vanguard ETFs to Buy in July

July is shaping up as a pivotal month for index investors. The S&P 500 has cooled a bit, with Vanguard S&P 500 ETF (NYSEARCA:VOO) down 1.36% since its year-to-date high on June 2 as the 10-year Treasury yield has eased to 4% and the VIX has settled at 17.65. With the Fed funds rate parked ... 4 Brilliant Vanguard ETFs to Buy in July

Tech Drives Market Rally as Stock Futures Pop
Barrons.com30d agobullish
Tech Drives Market Rally as Stock Futures Pop

U.S. stock futures looked set to open in the green early Monday, with the technology sector driving the gains. Corporate news is set to dominate the headlines in a light week for economic data, with the exception of Wednesday’s release of the Federal Reserve's minutes from its June monetary-policy meeting. Dow Jones Industrial Average futures were up 45 points, or 0.1%.

Cathie Wood buys $38.1 million of tumbling megacap stock
TheStreet31d agobullish
Cathie Wood buys $38.1 million of tumbling megacap stock

Cathie Wood, chief of Ark Investment Management, is known for buying “disruptive” tech stocks during market pullbacks. That’s what she just did, adding one of her highest-conviction investments, Tesla, as the stock fell more than 7% in a day. In 2025, the flagship Ark Innovation ETF gained 35.49%, ...

Cathie Wood buys $5.5M of surging tech stock
TheStreet33d agobullish
Cathie Wood buys $5.5M of surging tech stock

Cathie Wood, head of Ark Investment Management, is known for betting on disruptive technology companies, and investors closely watch every move she makes. Sometimes, she’ll even buy tech stocks on the way up — and that’s what she just did, adding shares of a tech company that’s rallied 5% over the ...

Small-Cap Rally Set to Fizzle in Second Half
Barrons.com33d agobullish
Small-Cap Rally Set to Fizzle in Second Half

Small caps are having a moment, but that doesn't mean the good times will keep rolling. The Russell 2000 gained 21.9% in the first half of 2026, crushing the S&P 500’s 9.6% in the same period, according to Dow Jones Market Data. The Federal Reserve is more hawkish, with investors expecting rate hikes before year end.

Investing.com35d agobullish
ServiceNow jumps 4% as Guggenheim flips from Neutral to Buy

Investing.com -- ServiceNow (NYSE:NOW) shares caught a 4% lift on Wednesday after Guggenheim analyst John DiFucci upgraded the software giant from Neutral to Buy, slapping on a $125 price target. After closing at $99.28 on Tuesday, DiFucci’s new target values the company at 7.5x EV/NTM Recurring Revenue—a premium compared to its SaaS peers, but a price Guggenheim argues is worth paying. "We believe current levels present an attractive opportunity for investors to purchase a comfortably profitabl

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC
Insider Monkey38d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]